Vivacelle Bio
Biotechnology, Clinical Trials, Health Care, Life Science
Founded in 2013-01-01
Chicago, Illinois, United States
For Profit
About Vivacelle Bio
Vivacelle Bio is a clinical stage biotechnology company focused on creating products that utilize phospholipid nanoparticle technology. The Company's first product, VBI-1, is a circulatory support fluid that is a colloid non-blood volume expander that appears to be two to three times more effective than the standard treatment for hypovolemia and safer in animal studies/experiments. It's second product, VBI-S, is specifically-designed to elevate blood pressure in septic shock patients. This new class of resuscitation fluids is called VIVACELLE.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: 16 active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 2448324 USD
- Last Funding: 1170824 USD (Series A)
- Funding Status: Early Stage Venture
Technology Stack
Vivacelle Bio actively uses 16 products in their tech stack.
Market Presence
Industries: Biotechnology, Clinical Trials, Health Care, Life Science
Headquarters: Chicago, Illinois, United States